Form 4 for RGNX REGENXBIO Inc.
Accepted 2021-11-10 00:00:00 ET · period of report 2021-11-08 · accession 0001562180-21-006967 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-11-10 | 2021-11-08 | RGNX | Mills Kenneth T. | Pres, CEO, Dir | M - OptEx | $3.76 | +1,500 | 282.5K | +0.5% | +$5,640 |
| D | 2021-11-10 | 2021-11-08 | RGNX | Mills Kenneth T. | Pres, CEO, Dir | S - Sale+OE | $40.00 | -1,500 | 281.0K | -0.5% | -$60.0K |
| D | 2021-11-10 | 2021-11-08 | RGNX | Mills Kenneth T. | Pres, CEO, Dir | M - OptEx | $0.00 | -1,500 | 229.9K | -0.6% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-11-08 | M | A | 1,500 | $3.76 | 282,484 | D | — | — | |
| 2 | Common | Common Stock | 2021-11-08 | S | D | 1,500 | $40.00 | 280,984 | D | — | — | |
| 3 | Derivative | Employee Stock Option (Right to Buy) | 2021-11-08 | M | D | 1,500 | $0.00 | 229,854 | D | $3.76 · — to 2025-05-18 | 1,500 Common Stock | (F2) The previously granted option, representing a right to purchase a total of 275,000 shares, became exercisable as follows: 25% of the shares subject to this option vested on May 19, 2016, and the balance vested in equal monthly installments over the 36 months thereafter. |